Drugs Made In America Acquisition II Ordinary Shares Current Cash

The latest current cash for DMII is $170K as of June 2026. That compares with $4.4K in the prior-year period — up 3882.1% year over year. Investors often review this figure alongside Drugs Made In America Acquisition II Ordinary Shares's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMII's current cash moved from $4.4K to $170K — a 3882.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Drugs Made In America Acquisition II Ordinary Shares's operating scale or balance-sheet position.

A current cash figure of $170K for DMII is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMII's current cash ($170K), review year-over-year change from $4.4K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.